Life Science Angels
VC Fund
Sunnyvale, United States
Life Science Angels is a VC fund in Sunnyvale focused on Biotechnology and Health Care. Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.
- Total investments:
- 95
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries Life Science Angels invests in
Stages Life Science Angels invests in
Countries Life Science Angels invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 14 contacts → | |||
Round size
- Seed
- $1M–$4M
- Series A
- $1.3M–$10M
Investment Focus
Industry
- Biotechnology 45 (47%)
- Health Care 44 (46%)
- Medical 20 (21%)
- Medical Device 18 (19%)
- Therapeutics 8 (8%)
Stage
- Seed 25 (26%)
- Series A 22 (23%)
- Funding Round 14 (15%)
- Venture - Series Unknown 11 (12%)
- Series B 9 (9%)
Country
- United States 64 (67%)
- Israel 1 (1%)
- The Netherlands 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Dan Bobear
Member
|
Member | Total investments: 0 | Find email | |
Shervin Majd
Digital Health Advisor and Investor
|
Digital Health Advisor and Investor | Total investments: 0 | Find email | |
Allan May
Co-Founder and Chairman
|
Co-Founder and Chairman | Total investments: 2 | Find email | |
Amitt Mehta
Member
|
Member | Total investments: 0 | Find email | |
Craig Harding
Member
|
Member | Total investments: 0 | Find email | |
| See all 14 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ATDev provides assistive technology and medical device solutions. | $3M / Seed / Oct 16, 2025 | ||
| Journey is a simple meditation practice designed for the modern world, providing on-demand and live-streamed meditation courses.Journey was created to share meditation in a way that all people could relate to, wherever they are in life. It has created a simple yet powerful technique that could appeal to a large-scale audience, changing a lot ofpeople’s lives. It takes a step beyond meditation by introducing six simple yet powerful Life Lessons.Founded in 2015 by Stephen Sokoler, Journey Meditation is headquartered in New York. | $8M / Series A / Jul 25, 2025 | ||
| Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California. | $3.1M / Seed / Dec 03, 2024 | ||
| Flyte is a femtech company that specializes in developing solutions to cure bladder leaks. It offers an in-home intravaginal device that both treats stress urinary incontinence and provides biofeedback to help patients strengthen pelvic floor muscles at home. | $2.3M / Seed / Apr 22, 2024 | ||
| Neurava has developed wearable diagnostics for epilepsy patients including those at risk of SUDEP. The company specializes in the fields of medical device manufacturing, healthcare, and health diagnostics. | $2.3M / Seed / Apr 03, 2024 | ||
| Savage Medical manufactures devices for medical use, enabling patients to get solutions for gastrointestinal diseases. They offer solutions for patients suffering from gastrointestinal diseases. | $3M / Venture - Series Unknown / Nov 28, 2023 | ||
| Avisi Technologies develops ophthalmic medical devices using nanotechnology to address vision loss associated with glaucoma and related eye conditions. The company designs implantable solutions such as VisiPlate, an aqueous shunt that regulates intraocular fluid through microchannel structures to help manage eye pressure. Its work combinesmaterials science and ophthalmology to create minimally invasive devices intended for long-term function within the eye. | $6.3M / Seed / Oct 01, 2023 | ||
| Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease. | $6M / Series B / Aug 18, 2023 | ||
| InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications. | $8.1M / Series A / Mar 22, 2022 | ||
| Avisi Technologies develops ophthalmic medical devices using nanotechnology to address vision loss associated with glaucoma and related eye conditions. The company designs implantable solutions such as VisiPlate, an aqueous shunt that regulates intraocular fluid through microchannel structures to help manage eye pressure. Its work combinesmaterials science and ophthalmology to create minimally invasive devices intended for long-term function within the eye. | $1.5M / Seed / Sep 01, 2021 | ||
| See all 95 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Life Science Angels invest in?
Life Science Angels invests primarily in Biotechnology, Health Care and Medical startups, most often at Seed and Series A stage. Most of the 95 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Life Science Angels invest in?
Life Science Angels typically joins rounds of $1M–$4M at Seed and $1.3M–$10M at Series A. These are whole funding-round sizes, not Life Science Angels's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Life Science Angels took part in.
How do I contact Life Science Angels?
Public channels for Life Science Angels include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Life Science Angels?
The team at Life Science Angels includes Dan Bobear (Member), Shervin Majd (Digital Health Advisor and Investor) and Allan May (Co-Founder and Chairman), among 14 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
